Hochschulschrift
Characterization of RNF43, a novel negative regulator of the Wnt signaling pathway
- Alternative title
-
Charakterisierung von RNF43, einem neuen negativen Regulator des Wnt Signalweges
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Technische Universität München, Diss., 2013
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der TU München
- (when)
-
2013
- Creator
-
Loregger, Anke
- Contributor
- URN
-
urn:nbn:de:bvb:91-diss-20130411-1115453-0-4
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Loregger, Anke
- Hrabé de Angelis, Martin
- Gerhard, Markus
- Universitätsbibliothek der TU München
Time of origin
- 2013
Other Objects (12)
Characterization of RNF43, a novel negative regulator of the Wnt signaling pathway
Identification and functional analysis of RAB8B as a regulator of Wnt/β-catenin [Wnt-beta-catenin] signaling pathway
Gtpbp2 is a positive regulator of Wnt signaling and maintains low levels of the Wnt negative regulator Axin
Identification and characterization of a novel negative regulator of Wnt signaling
Aldolase positively regulates of the canonical Wnt signaling pathway
Neuroglobin promotes neurogenesis through Wnt signaling pathway
The role of Wnt-β-catenin [Wnt-beta-catenin] signaling pathway in thyroid carcinomas
PLA2G7/PAF-AH as potential negative regulator of the Wnt signaling pathway mediates protective effects in BRCA1 mutant breast cancer
A reporter gene system for screening inhibitors of Wnt signaling pathway
Coffee interferes with HCV replication by inhibition of wnt signaling pathway
Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
Targeting the Wnt/β-catenin signaling pathway in cancer
Characterization of RNF43, a novel negative regulator of the Wnt signaling pathway
Identification and functional analysis of RAB8B as a regulator of Wnt/β-catenin [Wnt-beta-catenin] signaling pathway
Gtpbp2 is a positive regulator of Wnt signaling and maintains low levels of the Wnt negative regulator Axin
Identification and characterization of a novel negative regulator of Wnt signaling
Aldolase positively regulates of the canonical Wnt signaling pathway
Neuroglobin promotes neurogenesis through Wnt signaling pathway
The role of Wnt-β-catenin [Wnt-beta-catenin] signaling pathway in thyroid carcinomas
PLA2G7/PAF-AH as potential negative regulator of the Wnt signaling pathway mediates protective effects in BRCA1 mutant breast cancer
A reporter gene system for screening inhibitors of Wnt signaling pathway
Coffee interferes with HCV replication by inhibition of wnt signaling pathway
Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
Targeting the Wnt/β-catenin signaling pathway in cancer
Characterization of RNF43, a novel negative regulator of the Wnt signaling pathway
Identification and functional analysis of RAB8B as a regulator of Wnt/β-catenin [Wnt-beta-catenin] signaling pathway
Gtpbp2 is a positive regulator of Wnt signaling and maintains low levels of the Wnt negative regulator Axin
Identification and characterization of a novel negative regulator of Wnt signaling
Aldolase positively regulates of the canonical Wnt signaling pathway
Neuroglobin promotes neurogenesis through Wnt signaling pathway
The role of Wnt-β-catenin [Wnt-beta-catenin] signaling pathway in thyroid carcinomas
PLA2G7/PAF-AH as potential negative regulator of the Wnt signaling pathway mediates protective effects in BRCA1 mutant breast cancer
A reporter gene system for screening inhibitors of Wnt signaling pathway
Coffee interferes with HCV replication by inhibition of wnt signaling pathway
Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway